Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 751014, 11 pages
http://dx.doi.org/10.1155/2015/751014
Research Article

Heparin Interaction with the Primed Polymorphonuclear Leukocyte CD11b Induces Apoptosis and Prevents Cell Activation

1Eliachar Research Laboratory, Western Galilee Hospital, 22100 Nahariya, Israel
2Technion Faculty of Medicine, 3525433 Haifa, Israel
3Department of Nephrology and Hypertension, Western Galilee Hospital, 22100 Nahariya, Israel
4Department of Anesthesiology & Critical Care, VA San Diego Healthcare System, San Diego, CA 92161, USA
5Hematology Laboratory, Western Galilee Hospital, 22100 Nahariya, Israel

Received 17 August 2015; Revised 2 November 2015; Accepted 25 November 2015

Academic Editor: Eileen Uribe-Querol

Copyright © 2015 Meital Cohen-Mazor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Swain, T. T. Rohn, and M. T. Quinn, “Neutrophil priming in host defense: role of oxidants as priming agents,” Antioxidants and Redox Signaling, vol. 4, no. 1, pp. 69–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. B. Hallett and D. Lloyds, “Neutrophil priming: the cellular signals that say ‘amber’ but not ‘green’,” Immunology Today, vol. 16, no. 6, pp. 264–268, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Sharma, J. A. Askari, M. J. Humphries, E. Y. Jones, and D. I. Stuart, “Crystal structure of a heparin- and integrin-binding segment of human fibronectin,” The EMBO Journal, vol. 18, no. 6, pp. 1468–1479, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Mandal, T. W. Lyden, and M. G. Saklayen, “Heparin lowers blood pressure: biological and clinical perspectives,” Kidney International, vol. 47, no. 4, pp. 1017–1022, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Nelson, O. Cecconi, W. G. Roberts, A. Aruffo, R. J. Linhardt, and M. P. Bevilacqua, “Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation,” Blood, vol. 82, no. 11, pp. 3253–3258, 1993. View at Google Scholar · View at Scopus
  6. G. Bazzoni, A. Beltran Nunez, G. Mascellani, P. Bianchini, E. Dejana, and A. Del Maschio, “Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions,” The Journal of Laboratory and Clinical Medicine, vol. 121, no. 2, pp. 268–275, 1993. View at Google Scholar · View at Scopus
  7. K. Itoh, A. Nakao, W. Kishimoto, and H. Takagi, “Heparin effects on superoxide production by neutrophils,” European Surgical Research, vol. 27, no. 3, pp. 184–188, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Léculier, N. Couprie, P. Adeleine, P. Leitienne, A. Francina, and M. Richard, “The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes,” Thrombosis Research, vol. 69, no. 6, pp. 519–531, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. K. T. Kruse-Elliott, K. Chaban, J. E. Grossman, S. Tomasko, C. Kamke, and B. Darien, “Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor,” Shock, vol. 10, no. 3, pp. 198–202, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Matzner, G. Marx, R. Drexler, and A. Eldor, “The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis,” Thrombosis and Haemostasis, vol. 52, no. 2, pp. 134–137, 1984. View at Google Scholar · View at Scopus
  11. M. S. Diamond, R. Alon, C. A. Parkos, M. T. Quinn, and T. A. Springer, “Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18),” The Journal of Cell Biology, vol. 130, no. 6, pp. 1473–1482, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Walzog, F. Jeblonski, A. Zakrzewicz, and P. Gaehtgens, “β2 Integrins (CD11/CD18) promote apoptosis of human neutrophils,” The FASEB Journal, vol. 11, no. 13, pp. 1177–1186, 1997. View at Google Scholar · View at Scopus
  13. J. Manaster, J. Chezar, R. Shertz-Swirski et al., “Heparin induces apoptosis in human peripheral blood neutrophils,” British Journal of Haematology, vol. 94, no. 1, pp. 48–52, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Sela, R. Shurtz-Swirski, G. Shapiro et al., “Oxidative stress during hemodialysis: effect of heparin,” Kidney International Supplements, vol. 78, pp. S159–S163, 2001. View at Google Scholar
  15. J. W. Yoon, M. V. Pahl, and N. D. Vaziri, “Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease,” Kidney International, vol. 71, no. 2, pp. 167–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sela, R. Shurtz-Swirski, M. Cohen-Mazor et al., “Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 8, pp. 2431–2438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Kristal, R. Shurtz-Swirski, J. Chezar et al., “Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension,” American Journal of Hypertension, vol. 11, no. 8, pp. 921–928, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Gray, “Priming of neutrophil oxidative responses by platelet-activating factor,” Journal of Lipid Mediators, vol. 2, supplement, pp. S161–S175, 1990. View at Google Scholar · View at Scopus
  19. E. Majewska, Z. Sulowska, and Z. Baj, “Spontaneous apoptosis of neutrophils in whole blood and its relation to apoptosis gene proteins,” Scandinavian Journal of Immunology, vol. 52, no. 5, pp. 496–501, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. B. A. Dennissen, G. J. Jenniskens, M. Pieffers et al., “Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies,” The Journal of Biological Chemistry, vol. 277, no. 13, pp. 10982–10986, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. van den Born, K. Salmivirta, T. Henttinen et al., “Novel heparan sulfate structures revealed by monoclonal antibodies,” Journal of Biological Chemistry, vol. 280, no. 21, pp. 20516–20523, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. L. Capecchi, L. Ceccatelli, F. Laghi Pasini, and T. Di Perri, “Inhibition of neutrophil function in vitro by heparan sulfate,” International Journal of Tissue Reactions, vol. 15, no. 2, pp. 71–76, 1993. View at Google Scholar · View at Scopus